Barbee McCarthy (salespruce6)

Four real-life case studies have been done for the practical realization of the proposed energy management algorithm performance. Another significant contribution of this paper is the utilization of the solar PV power even during grid outage scenario at day time. It is made possible by intelligent interfacing of biogas power generator which acts as a reference AC bus for the grid-tied solar inverter and thus the available solar PV power can be used to serve the critical loads during grid outage condition. The proposed smart hybrid microgrid solution claims to be a generalized one, low cost compared to existing alternatives and applicable to satisfy scalable community energy security as well.A recent outbreak of endemic disease speeded by a virus whose genome is similar to that of SARS and MERS which outbreak in 2002 and 2012 respectively. All these are zoonotic infection which means these has transmitted from animal to human. Another similarity amongst these infections is that bat is supposed to be primary reservoir for these viruses. 2019-nCoV was reported by WHO on 31 December 2020 which is spreading with alarming rate. WHO has considered this infection as pandemic which means that if the infection is misled then it will spread fear and will cause unnecessary suffering and death. The onset of infection shows general symptoms of flu which later on develops to pneumonia. The main challenge of the infection is that a defined vaccine or medicine is still under trial. Treatment is done on the basis of symptoms and recovery is dependent on the immune response of the patients. This review article is based on meta-analysis of the data where the relation between reproduction number (R0) and infection rate is well depicted. Most of the countries has R0 > 1 which says the infection is epidemic. Symptoms and possible treatment till date is well defined in this paper. Though the COVID-19 virus has changed its strain and came up with asymptomatic infection which is more challenging. Here we present all the relevant information and facts about novel corona virus. At this time there are still major questions about the characteristics of disease caused by the new coronavirus (COVID-19) in children as well as factors associated with the development of severe forms of the disease. Retrospective study including patients under 18 years of age admitted with SARS-CoV-2 infection from March 1 to April 30, 2020. Infection was confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) or antibody testing. We describe the epidemiological and clinical data, laboratory and imaging findings, as well as treatment and outcome in these patients. In light of these findings, patients were classified into two severity groups and then compared. Thirty-nine children were included, with a median age of 9 years (range 12 days-16 years); 23 were boys. Cases with uncomplicated disease course (24) mostly presented to the emergency department (ED) with fever and/or respiratory symptoms without significant alterations in laboratory findings. Of the 15 children with a com symptoms without altered laboratory-test results generally have an uncomplicated course. Patients with complicated disease present mainly with fever and abdominal and/or mucocutaneous symptoms. Most develop shock. Elevation of inflammatory markers may allow for early detection and the final outcome is good.Antibody therapeutics and vaccines are among our last resort to end the raging COVID-19 pandemic.They, however, are prone to over 1,800 mutations uncovered by a Mutation Tracker. It is urgent to understand how vaccines and antibodies in the development would be impacted by mutations. In this work, we first study the mechanism, frequency, and ratio of mutations on the spike (S) protein, which is the common target of most COVID-19 vaccines and antibody therapies. Additionally, we build a library of antibody structures and analyze their 2D and 3D c